SCHEMBL2439686

SCHEMBL2439686

CC(C)COc1c(F)cc(-c2csc(NC(=O)CBr)n2)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 6/20 0.53
ABL1 P00519 5/20 0.47
CYP3A4 P08684 1/20 0.44
AAK1 Q2M2I8 1/20 0.44
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
RAB9A P51151 3/20 0.43
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480940 0.93 TRPA1 (0.59) TRPA1MEN1KMT2ARAB9ANPC1
SCHEMBL480411 0.93 TRPA1 (0.58) TRPA1ABL1CYP3A4MEN1KMT2A
SCHEMBL15580544 0.89 TRPA1 (0.50) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL2453828 0.88 ABL1 (0.48) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL2440259 0.87 TRPA1 (0.49) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL480700 0.86 TRPA1 (0.55) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL2453157 0.86 TRPA1 (0.48) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL10171794 0.86 TRPA1 (0.48) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL480355 0.85 TRPA1 (0.60) TRPA1ABL1MEN1KMT2ARAB9A
SCHEMBL2445209 0.84 FFAR4 (0.50) TRPA1ABL1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114184-A1 AMIDES OF HETEROCYCLIC COMPOUNDS AS TRPA1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-09-22 WO disclosed
WO-2011114184-A1 AMIDES OF HETEROCYCLIC COMPOUNDS AS TRPA1 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-09-22 WO disclosed